More than 1,000 Scientists Share Advice to Increase DEI across the Industry Leading to the Change Hypothesis

The Extraordinary Grace keynote launch discusses the transformation and progress of DEI in STEM FRAMINGHAM, Mass.–(BUSINESS WIRE)–#EL–The Extraordinary Grace initiative, started in 2021 by SCIEX, called on members of the scientific community to share what diversity, equity and inclusion (DEI) means to them and to guide a digital scientist representing the next generation of science, … [Read more…]

PharmaJet Presents Latest Research Showing Benefits of Needle-free at mRNA-Based Therapeutics Summit

Needle-free can increase immunogenicity, reduce costs, and improve patient experience GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that they will present their latest research results at the mRNA-Based Therapeutics Summit on July 27, 2022. The presentation, entitled Advances in mRNA … [Read more…]

CPSI to Webcast Its Second Quarter 2022 Conference Call

MOBILE, Ala.–(BUSINESS WIRE)–$CPSI–CPSI (NASDAQ: CPSI), a community healthcare solutions company, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 2, 2022, after the market closes. The Company will host a conference call at 4:30 p.m. Eastern Time that same day. The live broadcast of … [Read more…]

Bionic Clothing Innovator CIONIC Announces Collaboration with Yves Behar’s fuseproject

Breakthrough Cionic Neural Sleeve Redefines the Future of Human Mobility SAN FRANCISCO–(BUSINESS WIRE)–CIONIC announces a collaboration with acclaimed designer Yves Behar and his world-renowned multidisciplinary design firm, fuseproject. The collaboration between fuseproject and CIONIC marries thoughtfully inclusive design with revolutionary mobility technology to deliver the Cionic Neural Sleeve, an FDA-cleared bionic leg wearable that uses … [Read more…]

India In Vitro Diagnostics (IVD) Market Analysis Report 2021-2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostics (IVD) in India” report has been added to ResearchAndMarkets.com’s offering. This new report is designed to provide an overview of the IVD market in India and its influences. Included in the report are trends influencing the industry and country-level data including the incidence of disease, life expectancy, population demographics, economic … [Read more…]

Hyfe Joins Forces with Merck to Deploy Its Artificial Intelligence-Powered Cough Detection and Counting Technology

Partnership will offer easy-to-use app and personalized cough frequency information to consumers including the estimated 12 million adults in the U.S. who suffer from chronic cough1 NEW YORK–(BUSINESS WIRE)–Hyfe, Inc., the global leader in AI-powered cough detection, tracking and classification, has entered into an agreement with Merck, known as MSD outside the United States and … [Read more…]

CloudWave Announces New Board Member

Healthcare Cloud Services Provider Adds Seasoned Executive to Board of Directors to Assist with Driving Growth and Market Expansion MARLBOROUGH, Mass.–(BUSINESS WIRE)–CloudWave, the largest independent cloud and managed services software hosting provider in healthcare, is pleased to announce the appointment of Derek Pickell to its Board of Directors. Derek Pickell is currently Chief Executive Officer … [Read more…]

Cartography Biosciences Launches to Accelerate Precision Immunotherapy with Comprehensive Antigen Profiling

With $57M in initial financing, Cartography is creating immunotherapies that are more precise and more effective Cartography is combining cutting-edge computational and experimental techniques to profile antigens on normal and cancerous cells, creating a transformative roadmap by classifying cancers by antigen expression rather than tissue type or genetic mutation Founding team includes leaders of top … [Read more…]

SYNAPS Dx Showcases Autopsy-Confirmed Results for DISCERN Alzheimer’s Test MI Biomarker, For Identifying Alzheimer’s in Presence of Other Co-Morbid Pathologies

ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to announce its upcoming presentation of “Autopsy-Confirmed Minimally Invasive Biomarker Identifies Alzheimer’s Disease even in the Presence of Co-Morbid Pathologies” at the Alzheimer’s Association International Conference (AAIC), July 31 … [Read more…]